The Latest Breaking News from FDA

The Supreme Court announced on Friday it will decide disputes about the scope of Nuclear Regulatory Commission power and more.

The pharmaceutical industry is promising due to AI and biotech innovations enhancing productivity, steady profits amidst economic shifts, rising chronic illnesses, and strong growth projections in global revenues and biotechnology markets. Therefore, it could be wise to invest in pharma stocks such as AbbVie (ABBV), Bristol-Myers Squibb (BMY), and Gilead…

Dilated cardiomyopathy in dogs is a common heart disease – our vet tells you everything you need to know about this serious condition.

The new law, part of the California School Food Safety Act, bans the use of six artificial dyes: Red 40, Yellow 5, Yellow 6, Blue 1, Blue 2, and Green 3, in food and drinks served at public schools.

Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical company.

The S&P 500 Index ($SPX ) (SPY ) Friday closed down by -0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.33%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.53%. Stocks on Friday settled mixed, with the Dow Jones Industrials climbing...

The S&P 500 Index ($SPX ) (SPY ) today is down by +0.09%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.45%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.36%. Stocks today are mixed, with the Dow Jones Industrials climbing to...

The US Food and Drug Administration has approved Cobenfy, which is owned by pharmaceutical firm Bristol Myers Squibb.

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.04%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.93%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.30%. Stocks today are mixed, with the Dow Jones Industrials climbing to...